Vinay Prasad

Associate Professor

  • 2690 Citations
  • 26 h-Index
20092019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2009 2019

Filter
Letter
2019

Reply to C.J. Sweeney et al

Parikh, R. B. & Prasad, V., Jan 1 2019, In : Journal of Clinical Oncology. 37, 19, p. 1680-1681 2 p.

Research output: Contribution to journalLetter

2018
1 Citation (Scopus)

Brentuximab vedotin for frontline Hodgkin lymphoma: How much will a successful trial cost patients and payers?

Shanbhag, S. & Prasad, V., Nov 1 2018, In : European Journal of Cancer. 104, p. 252-253 2 p.

Research output: Contribution to journalLetter

Hodgkin Disease
Costs and Cost Analysis
cAC10-vcMMAE
1 Citation (Scopus)

Cost-effectiveness of nusinersen for spinal muscular atrophy: Reply

Prasad, V., Jul 1 2018, In : JAMA Pediatrics. 172, 7, p. 701-702 2 p.

Research output: Contribution to journalLetter

Spinal Muscular Atrophy
Cost-Benefit Analysis
1 Citation (Scopus)

Crossover is not associated with faster trial accrual

Chen, E. Y. & Prasad, V., Mar 1 2018, In : Annals of Oncology. 29, 3, p. 776-777 2 p., mdx821.

Research output: Contribution to journalLetter

1 Citation (Scopus)

Inconsistent reporting of potential conflicts of interest

Prasad, V., Jul 24 2018, In : JAMA - Journal of the American Medical Association. 320, 4, 1 p.

Research output: Contribution to journalLetter

Conflict of Interest

Inconsistent Reporting of Potential Conflicts of Interest

Prasad, V., Sep 1 2018, In : JAMA Pediatrics. 172, 9, 1 p.

Research output: Contribution to journalLetter

Conflict of Interest

Inconsistent Reporting of Potential Conflicts of Interest

Prasad, V., Oct 1 2018, In : JAMA Internal Medicine. 178, 10, p. 1424-1425 2 p.

Research output: Contribution to journalLetter

Conflict of Interest
1 Citation (Scopus)

Inconsistent Reporting of Potential Conflicts of Interest

Prasad, V., Oct 1 2018, In : JAMA oncology. 4, 10, 1 p.

Research output: Contribution to journalLetter

Conflict of Interest
2 Citations (Scopus)

In reply

Mailankody, S. & Prasad, V., Apr 1 2018, In : JAMA oncology. 4, 4, p. 586-587 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

In reply

Prasad, V., Kaestner, V. & Mailankody, S., Sep 1 2018, In : JAMA oncology. 4, 9, p. 1300-1301 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

In reply

Prasad, V. & Mailankody, S., Apr 1 2018, In : JAMA Internal Medicine. 178, 4, p. 588-589 2 p.

Research output: Contribution to journalLetter

17 Citations (Scopus)

Total costs of chimeric antigen receptor T-cell immunotherapy

Hernandez, I., Prasad, V. & Gellad, W. F., Jul 1 2018, In : JAMA oncology. 4, 7, p. 994-996 3 p.

Research output: Contribution to journalLetter

T-Cell Antigen Receptor
Immunotherapy
Costs and Cost Analysis
2017
1 Citation (Scopus)

A further strategy to combat the high price of anticancer drugs

Prasad, V., De Jesús, K. & Mailankody, S., Oct 1 2017, In : Nature Reviews Clinical Oncology. 14, 10, 1 p.

Research output: Contribution to journalLetter

Pharmaceutical Preparations
2 Citations (Scopus)

Clinically meaningful benefit: Real world use compared against the American and European guidelines

Dreicer, J. J., Mailankody, S., Fahkrejahani, F. & Prasad, V., Dec 1 2017, In : Blood Cancer Journal. 7, 12, 645.

Research output: Contribution to journalLetter

Guidelines
3 Citations (Scopus)

Conflicts of interest in Twitter

Kaestner, V., Brown, A., Tao, D. & Prasad, V., Sep 1 2017, In : The Lancet Haematology. 4, 9, p. e408-e409

Research output: Contribution to journalLetter

Conflict of Interest
1 Citation (Scopus)

Financial conflicts of interest among editorialists in high-impact journals

Kaestner, V. & Prasad, V., Sep 15 2017, In : Blood Cancer Journal. 7, 9, p. e611

Research output: Contribution to journalLetter

Conflict of Interest
14 Citations (Scopus)

Financial conflicts of interest among hematologist-oncologists on Twitter

Tao, D. L., Boothby, A., McLouth, J. & Prasad, V., Mar 1 2017, In : JAMA Internal Medicine. 177, 3, p. 425-427 3 p.

Research output: Contribution to journalLetter

Conflict of Interest
Oncologists
2 Citations (Scopus)

In reply

Beer, T. T. & Prasad, V., Nov 1 2017, In : JAMA oncology. 3, 11, p. 1588-1589 2 p.

Research output: Contribution to journalLetter

Hematology
Industry
Medicine
9 Citations (Scopus)

The rising price of cancer drugs- a newold problem?

Prasad, V., Wang, R., Afifi, S. H. & Mailankody, S., Feb 1 2017, In : JAMA oncology. 3, 2, p. 277-278 2 p.

Research output: Contribution to journalLetter

Pharmaceutical Preparations
Neoplasms
1 Citation (Scopus)
Drug Approval
Publications
Food
Pharmaceutical Preparations
Neoplasms
1 Citation (Scopus)

To the editor

Friedberg, M. W., Gellad, W. F. & Prasad, V., Jul 1 2017, In : JAMA Internal Medicine. 177, 7, p. 1058 1 p.

Research output: Contribution to journalLetter

To the Editor

Redberg, R. F. & Prasad, V., Aug 24 2017, In : New England Journal of Medicine. 377, 8, p. 786-787 2 p.

Research output: Contribution to journalLetter

2016
7 Citations (Scopus)

Future jobs of FDA's haematology-oncology reviewers

Bien, J. & Prasad, V., 2016, In : BMJ (Online). 354, i5055.

Research output: Contribution to journalLetter

Hematology
9 Citations (Scopus)

Industry Funding of Cancer Patient Advocacy Organizations

Abola, M. V. & Prasad, V., Nov 1 2016, In : Mayo Clinic Proceedings. 91, 11, p. 1668-1670 3 p.

Research output: Contribution to journalLetter

Patient Advocacy
Industry
Organizations
Neoplasms
19 Citations (Scopus)

The Use of Superlatives in Cancer Research

Abola, M. V. & Prasad, V., Jan 1 2016, In : JAMA oncology. 2, 1, p. 139-141 3 p.

Research output: Contribution to journalLetter

Marketing of Health Services
Consumer Health Information
Mass Media
Antineoplastic Agents
Biomedical Research
2015
29 Citations (Scopus)

Authorship inflation in medical publications

Tilak, G., Prasad, V. & Jena, A. B., 2015, In : Inquiry. 52

Research output: Contribution to journalLetter

Authorship
Economic Inflation
Publications
Growth
Population Density
125 Citations (Scopus)

Five Years of Cancer Drug Approvals: Innovation, Efficacy, and Costs

Mailankody, S. & Prasad, V., Jul 1 2015, In : JAMA oncology. 1, 4, p. 539-540 2 p.

Research output: Contribution to journalLetter

Device Approval
Diffusion of Innovation
Drug Approval
Drug Costs
Economic Inflation

Pricing and Value of Cancer Drugs--Reply

Mailankody, S. & Prasad, V., Sep 1 2015, In : JAMA oncology. 1, 6, p. 842-843 2 p.

Research output: Contribution to journalLetter

Device Approval
Diffusion of Innovation
Drug Costs
Antineoplastic Agents
2014
3 Citations (Scopus)

Exemestane with varian suppression in premenopausal Breast Cancer

Prasad, V., Oct 2 2014, In : New England Journal of Medicine. 371, 14, p. 1358 1 p.

Research output: Contribution to journalLetter

exemestane
Androstadienes
Antineoplastic Combined Chemotherapy Protocols
Triptorelin Pamoate
Tamoxifen
2013

Firearm legislation and gun-related fatalities

Jena, A. B., Sun, E. C. & Prasad, V., Nov 25 2013, In : JAMA Internal Medicine. 173, 21, 1 p.

Research output: Contribution to journalLetter

Firearms
Legislation